Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Eiji Mizuta is active.

Publication


Featured researches published by Eiji Mizuta.


FEBS Letters | 1989

Solution conformation of endothelin determined by nuclear magnetic resonance and distance geometry

Satoshi Endo; Hiroshi Inooka; Yoshihiro Ishibashi; Chieko Kitada; Eiji Mizuta; Masahiko Fujino

Endothelin; Vasoconstrictor peptide; Three‐dimensional structure; NMR, 1H; Distance geometry


Tetrahedron | 1968

A novel photo-induced methylation of pyrimidines and condensed pyrimidines☆

Michihiko Ochiai; Eiji Mizuta; Yutaka Asahi; Katsura Morita

Abstract A new photo-induced methylation of pyrimidines and condensed pyrimidines by irradiating an acidic solution of the bases in methanol is described. The scope and limitation, effects of acids, the calculation of the reactivity indices by the MO method, effect of bases on ·CH2OH radical formation, and the reaction mechanism are discussed.


Chemical & Pharmaceutical Bulletin | 1976

Conformational Analysis of 1,1a, 6,10b-Tetrahydrodibenzo [b, f]-cycloprop [d] azepine Derivatives

Kenya Kawashima; Eiji Mizuta

Detailed inspection of the nuclear magnetic resonance spectra of 1, 1a, 6, 10b-tetrahydrodibenzo [b, f] cycloprop [d] azepines (1) in CDCl3 solutions has revealed that the state of conformational equilibrium falls into the following five categories according to the nitrogen substituent Z : 1) There exists a slow equilibrium between conformers I and IV, conformers II and III being either involved in a fast process or not involved at all. 2) Thre eexists a slow (much slower than category 1) equilibrium between conformers I and IV, conformers II and III being either involved in a fast process or not involved at all. 3) Conformer I is the sole one that is present, conformer III being either involved in a fast process or not involved at all. 4) Conformer IV (≡II) is the sole one that is present. 5) There exists a fast equilibrium between conformers I and IV, conformers II and III being either involved in a fast process or not involved at all.


Chemical & Pharmaceutical Bulletin | 1985

Preparation of Mean Drug Concentration-Time Curves in Plasma. A Study on the Frequency Distribution of Pharmacokinetic Parameters

Eiji Mizuta; Atsuko Tsubotani


Tetrahedron | 1979

Isolation, chemical characterization and structure of ansamitocin, a new antitumor ansamycin antibiotic

Mitsuko Asai; Eiji Mizuta; Motowo Izawa; Konomi Haibara; Toyokazu Kishi


Chemical & Pharmaceutical Bulletin | 1982

The Granulation-Inhibiting Principles from Eucalyptus globulus LABILL. III. The Structures of Euglobal-III, -IVb and -VII

Mutsuo Kozuka; Tokunosuke Sawada; Eiji Mizuta; Fumiko Kasahara; Toshio Amano; Takeya Komiya; Minoru Goto


Chemical & Pharmaceutical Bulletin | 1982

The Granulation-Inhibiting Principles from Eucalyptus globulus LABILL. II. The Structures of Euglobal -Ia1, -Ia2, -Ib, -Ic, -IIa, -IIb and -IIc

Mutsuo Kozuka; Tokunosuke Sawada; Fumiko Kasahara; Eiji Mizuta; Toshio Amano; Takeya Komiya; Minoru Goto


International Journal of Peptide and Protein Research | 2009

Pituitary adenylate cyclase activating polypeptide (PACAP) with 27 residues : conformation determined by 1H NMR and CD spectroscopies and distance geometry in 25% methanol solution

Hiroshi Inooka; Satoshi Endo; Chieko Kitada; Eiji Mizuta; Masahiko Fujino


Chemical & Pharmaceutical Bulletin | 1984

The absolute configuration of P-1894B, a potent prolyl hydroxylase inhibitor

Kazuhiko Ohta; Eiji Mizuta; Hisayoshi Okazaki; Toyokazu Kishi


Yakugaku Zasshi-journal of The Pharmaceutical Society of Japan | 1982

[Studies on anti-inflammatory agents. VI. Anti-inflammatory constituents of Cinnamomum sieboldii Meissn (author's transl)].

Hiroshi Otsuka; Shoji Fujioka; Takeya Komiya; Eiji Mizuta; Masayuki Takamoto

Collaboration


Dive into the Eiji Mizuta's collaboration.

Top Co-Authors

Avatar

Yutaka Asahi

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Mikio Hori

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Tadashi Kataoka

Gifu Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Atsuko Tsubotani

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Hiroshi Inooka

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Kazuyoshi Katamoto

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Kiyoshi Nara

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Masahiko Fujino

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Masao Nishikawa

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Mitsuko Asai

Takeda Pharmaceutical Company

View shared research outputs
Researchain Logo
Decentralizing Knowledge